[Predictive Value of HLA-DRB1 Gene for the Treatment of Unexplained Recurrent Spontaneous Abortion with Paternal Lymphocyte Alloimmunization Therapy in Henan Hans].

Ke Yang,Bing Zhang,Shixiu Liao,Miao He,Yan Chu,Qiancheng Li,Qiannan Guo,Qiaofang Hou,Xuebing Ding
DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2014.03.027
2014-01-01
Abstract:OBJECTIVE:To explore the value of HLA-DRB1 gene in predicting the outcome of unexplained recurrent spontaneous abortion (URSA) treated with paternal lymphocyte alloimmunization therapy (PLAT) in Henan Hans.METHODS:Three hundred URSA patients were recruited. Following PLAT treatment, they were divided into two groups according to the outcome of pregnancy. Polymerase chain reaction sequence specific primer (PCR-SSP) were conducted to analyze the HLA-DRB1 gene.RESULTS:For those who have received PLAT treatment, the frequency of HLA-DRB1*11 was significantly lower in successfully treated cases than those with abortion (0.052 vs. 0.110, P < 0.05, OR=0448), whilst the frequency of HLA-DRB1*15 was significantly greater in the former (0.207 vs. 0.100, P < 0.05, OR=2.352).CONCLUSION:For patients who have received PLAT treatment, those with HLA-DRB1*15 are more likely to conceive that those with HLA-DRB1*11.
What problem does this paper attempt to address?